Thereafter, we reported the in vivo reduction in neutrophil elastase (NE) and myeloperoxidase (MPO) in neutrophils from RA patients after six months of treatment with the IL-6R inhibitor tocilizumab [39]. Here, ELANE is linked to rheumatoid arthritis.